RuDo Logo
Talk to an adviser

State Street SPDR S&P Biotech ETF

XBI · SPDR

$140.18

-$3.94 (-2.73%) today

20 Nov 2026 close · USD · AED 514.81

XBI -6.89%S&P 500 (SPY) -8.56%past 5 days

Returns

Up to a year

PeriodXBIS&P 500 (SPY)
1 month-8.52%-10.30%
3 months-14.20%-9.32%
6 months+6.54%-6.47%
This year+15.08%+1.95%
1 year+23.68%+6.86%

Longer term

XBIS&P 500 (SPY)
TotalA yearA year
2 years+49.83%+22.4%+9.3%
3 years+91.95%+24.3%+16.3%
5 years+15.70%+3.0%+9.5%
7 years+61.61%+7.1%+13.6%
10 years+115.4%+8.0%+13.9%
Since inception+868.8%+11.8%+10.6%

$10,000 invested 10 years ago is $21,543 today.

Dividends reinvested, to 20 Nov 2026. Past returns are no guide to the future.

RiskWorst fall -63.9% (Feb 2021 to May 2022) · ups and downs 28.1% a year

Volatility, 3 years

28.1%

SPY 15.7%

Worst fall

-63.9%

May 2022, not yet back

Worst calendar year

-25.9%

2022

Up months

61%

last 3 years

More measures ›

Sharpe ratio, 3 years

0.71

Return above US Treasury bills per unit of volatility

Beta vs S&P 500

0.96

Moves about 0.96% when SPY moves 1%

Correlation with S&P 500

0.50

1 means they move together; 0 means unrelated

Share of the benchmark's rises

126%

In months the benchmark rose

Share of the benchmark's falls

90%

In months the benchmark fell; lower is better

Over the last 36 months, from monthly total returns against S&P 500 (SPY).

What stands outAgainst 4 healthcare ETFs

What it holds

165 holdings · as of 18 Nov 2026

  1. 1MODERNA INC2.37%
  2. 2BIOGEN INC1.85%
  3. 3REGENERON PHARMACEUTICALS1.85%
  4. 4EXELIXIS INC1.83%
  5. 5GILEAD SCIENCES INC1.82%
  6. 6AMGEN INC1.82%
  7. 7ABBVIE INC1.82%
  8. 8UNITED THERAPEUTICS CORP1.79%
  9. 9TG THERAPEUTICS INC1.79%
  10. 10SPYRE THERAPEUTICS INC1.68%
Top 10: 18.6% of the fund

Download daily prices (CSV) · Compare with other ETFs · Today's ETF movers · My list

XBI, State Street SPDR S&P Biotech ETF: summary

State Street SPDR S&P Biotech ETF (XBI) is an equity ETF from SPDR, launched on 31 Jan 2006. It is domiciled in the United States. The expense ratio is 0.35% a year. It manages $9.6 billion. It holds 165 securities. The price was $140.18 on 20 Nov 2026.

Similar ETFs: XLV, VHT, IBB

Compare with similar ETFs: Healthcare and biotech ETFs

Questions about XBI

What is the expense ratio of XBI?

0.35% a year. It comes out of the fund's assets, so the price and the returns shown are already after this cost.

What has XBI returned?

State Street SPDR S&P Biotech ETF returned 23.7% over 1 year, 24.3% a year over 3 years, 3.0% a year over 5 years and 8.0% a year over 10 years, with dividends reinvested.

What should UAE residents know before holding XBI?

XBI is domiciled in the United States, so its shares count as US assets. If a person who is not a US citizen or resident dies holding more than US$60,000 of US assets, US estate tax can apply, at rates up to 40%. The UAE has no income tax treaty with the United States, so dividends usually have 30% withheld. Ireland-domiciled UCITS ETFs are generally not treated as US assets for estate tax, and pay 15% on US dividends under the US and Ireland treaty. Confirm your own position with a tax adviser.

For investors living in the UAE

This ETF is domiciled in the United States, so its shares count as US assets. If a person who is not a US citizen or resident dies holding more than US$60,000 of US assets, US estate tax can apply, at rates that rise to 40%.

The UAE has no income tax treaty with the United States, so US dividends paid to a UAE resident usually have 30% withheld. Ireland-domiciled UCITS ETFs that hold US shares are generally not treated as US assets for estate tax, and the fund pays 15% on its US dividends under the US and Ireland treaty.

UCITS alternatives to XBI in US dollars

The biggest Irish-domiciled funds of the same kind (Healthcare and biotech ETFs) that trade in US dollars.

See every UCITS ETF in US dollars · Compare XBI with them

The outcome depends on your nationality, residence and facts, so confirm your own position with a tax adviser. Sources: IRS, estate tax for nonresidents and US income tax treaties, checked October 2026.

About this data

ETF data comes from RuDo Wealth market data, with returns as of 20 Nov 2026. We order ETFs by published measures such as returns, volatility, cost and size, and we do not label any ETF as the best. Method reviewed by Alok Kumar, Chief Executive Officer, RuDo Digital Wealth, October 2026.

RuDo Wealth is a fee-only cross-border advisory operating through two separate companies. India: RuDo Wealth Investment Advisory, SEBI Registered Investment Adviser, registration INA000019503. UAE: RuDo Digital Wealth, FSRA Financial Services Permission 220155, Category 3C (Retail), ADGM. The entity permitted to serve you depends on your country of residence.

This page is general information, not a recommendation to buy or sell this ETF. Tax on ETF gains, dividends and estates depends on where you live and where the ETF is domiciled, so confirm your own position with a tax adviser. Past performance does not indicate future returns.